Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
MitoRx Therapeutics Logo
MitoRx Therapeutics Growth Score
52
CB Rank
20851
Heat Score
77
MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.
Founded
obfuscation
PrivateSeed Harwell, Oxfordshire, United Kingdom11-50 www.mitorxtherapeutics.com/
Biotechnology
Therapeutics
Overview

MitoRx Therapeutics
Total Funding
obfuscation
Growth Score
52
Heat Score
77

Total Funding
obfuscation
Seed raised
obfuscation
Growth Score52
-1 pts
in past quarter
Heat Score 77
9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About MitoRx Therapeutics

CB Rank
20851
MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.
Founded
obfuscation
PrivateSeed Harwell, Oxfordshire, United Kingdom11-50 www.mitorxtherapeutics.com/
Biotechnology
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name MitoRx Therapeutics Limited
Operating Status Active
Company Type For Profit
About the Company
MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.
Predictions & Insights

Growth Insight

See this Growth Insight
MitoRx Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

mtH2SD Technology
A mitochondrial-targeted sulfide donor platform designed to restore mitochondrial function by replenishing sulfide signaling in diseases with trans-sulfuration deficiency.
AP39
A mitochondrial-targeted hydrogen sulfide donor compound that reduces obesity and fatty liver by modulating lipid metabolism and inflammation pathways.

Research & Development

MitoRx Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - MitoRx Therapeutics Logo
Seed Round - MitoRx Therapeutics
1
obfuscation
— Seed
obfuscation
Seed Round - MitoRx Therapeutics Logo
Seed Round - MitoRx Therapeutics
1
obfuscation
— Seed
obfuscation
Seed Round - MitoRx Therapeutics Logo
Seed Round - MitoRx Therapeutics
1
obfuscation
— Seed
obfuscation
Seed Round - MitoRx Therapeutics Logo
Seed Round - MitoRx Therapeutics
1
obfuscation
— Seed
obfuscation
Seed Round - MitoRx Therapeutics Logo
Seed Round - MitoRx Therapeutics
1
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - MitoRx Therapeutics Logo
Seed Round - MitoRx Therapeutics
1
obfuscation
— Seed
obfuscation
Seed Round - MitoRx Therapeutics Logo
Seed Round - MitoRx Therapeutics
1
obfuscation
— Seed
obfuscation
Seed Round - MitoRx Therapeutics Logo
Seed Round - MitoRx Therapeutics
1
obfuscation
— Seed
obfuscation
Seed Round - MitoRx Therapeutics Logo
Seed Round - MitoRx Therapeutics
1
obfuscation
— Seed
obfuscation
Seed Round - MitoRx Therapeutics Logo
Seed Round - MitoRx Therapeutics
1
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Contacts 5

Employee Profiles

News

News and Press

News•Jun 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 9, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 9, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

613
666.25%
 in past month

IT Spend

$53.3KThis year, MitoRx Therapeutics is projected to spend $53.3K on IT, according to Aberdeen.

Active Website Tech Count

2MitoRx Therapeutics is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 10m.

Total IP

3The intellectual property of MitoRx Therapeutics includes 3 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is MitoRx Therapeutics's headquarters? MitoRx Therapeutics is located in Harwell, Oxfordshire, United Kingdom.Who invested in MitoRx Therapeutics? MitoRx Therapeutics has 8 investors including Panacea Capital and  Empirical Ventures.When was the last funding round for MitoRx Therapeutics? MitoRx Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are MitoRx Therapeutics's competitors? Alternatives and possible competitors to MitoRx Therapeutics may include BioAge Labs, Persivia, and  Stealth BioTherapeutics.How much funding has MitoRx Therapeutics raised to date? MitoRx Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(b944491 1)
|